OSTX

0.80302.12%
JC

John Ciccio

Independent Director

Mr. John Ciccio serves as Director since November 7, 2025 at MedAdvisor Limited and serves its Chief Executive Officer and Managing Director since 2025. He is COO, Technology & Data Solutions of Syneos Health Inc. He was President and CEO of Adheris Health, a MedAdvisor company. He was Chief Executive Officer of Adheris at MedAdvisor Limited since November 17, 2020. He serves as Independent Director of OS Therapies Incorporated since December 2020. He serves as Vice President of Strategic Business Development at Adheris, Inc. Prior to joining Adheris Health, Mr. Ciccio was the President and a member of the board of managers of Skipta Limited Liability Company from 2014 to 2018, where he played a critical role in Skipta sale to Informa PLLC. Prior to Joining OS Therapies Inc, he worked on several consulting engagements-primarily focused in the pharmaceuticals industry-as an Analyst with Braun Consulting. While with Braun, his casework included launch strategy for an immunosuppressive agent, market sizing and segmentation for an oncology medication and cluster analysis and marketing strategy for a large consumer electronics retailer. Mr. Ciccio has also served as a member of the board of directors of Full Code Medical Simulation since March 2022. He holds a Bachelor of Arts degree in Government from Harvard University.

Positions